• Skip to primary navigation
  • Skip to content

Design Garden

Resources for Biomedical Engineering Device Design

  • Home
  • Design Resources
    • Voice of the Customer
    • User Needs and Design Inputs
    • Regulatory Affairs
    • Ideation
    • Intellectual Property
    • Market Assessment
    • Prototyping Resources
  • Global Health Capstone
  • Contact Us
  • Recommendations
  • Startups & Student Ventures
  • STAT Credentialing Program
  • Spring 2025 Expo Showcase
    • Fall 2024 Expo Showcase
    • Spring 2024 Expo Showcase

F24 Astreos

Get to know our team on LinkedIN:

Joe Irwin: linkedin.com/in/joseph-p-irwin

Mahatru Miryala: linkedin.com/in/mahatrum

Daniel Lai: linkedin.com/in/daniel-n-lai

Ryan Brown: linkedin.com/in/rjb111

Ben Soboloff: linkedin.com/in/benjamin-soboloff-039867171

Kermit Avera: linkedin.com/in/kermit-avera-7102621b7

Astreos

 

 An auto-injector that delivers medications to astronauts without compromising suit integrity

A rendered image of the prototype

Project Description:

Space agencies like NASA are planning ambitious Moon and Mars expeditions within the decade. The last manned mission to the Moon was in 1969, and these new journeys will require advanced technology to support long durations. A key area for development is medical equipment, especially for extended ground explorations. These explorations can present medical difficulties such as physical ailments and sicknesses. Thus, a space-compatible solution needs to be developed to address these scenarios. The proposed device in this report is a spaceflight injectable system that can be activated whenever an astronaut is outside of their spacecraft. This device specifically looks to address scenarios when the astronauts are in their Extravehicular Mobility Units (EMUs). These EMUs keep the astronaut separated from space via a thick layer of fabric, which presents a clear safety issue when trying to penetrate this barrier with a needled device. Penetrating the suit without compromising its integrity is essential to ensuring the safety of the astronaut while administering medical care. Thus, to ensure device efficacy, the device will need to inject while limiting the leak rate of Oxygen to 10^-4 cc/sec.

Dr. Aaron Weaver

NASA

 

Copyright © 2025 · Maker Pro on Genesis Framework · WordPress · Log in